Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2012, Article ID 213403, 13 pages
http://dx.doi.org/10.1155/2012/213403
Review Article

Inhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct versus Indirect Mechanisms

LabEx LERMIT, INSERM U769, Faculté de Pharmacie, Université Paris-Sud, 5 Rue J.-B. Clément, 92290 Châtenay-Malabry, France

Received 22 December 2011; Accepted 7 February 2012

Academic Editor: Etienne Jacotot

Copyright © 2012 Cécile Martel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Lehninger, “The transfer of energy in oxidative phosphorylation,” Bulletin de la Société de Chimie Biologique, vol. 46, pp. 1555–1575, 1964. View at Google Scholar
  2. G. Kroemer, L. Galluzzi, and C. Brenner, “Mitochondrial membrane permeabilization in cell death,” Physiological Reviews, vol. 87, no. 1, pp. 99–163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-C. Martinou and R. Youle, “Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics,” Developmental Cell, vol. 21, no. 1, pp. 92–101, 2011. View at Publisher · View at Google Scholar
  4. G. Majno and I. Joris, “Apoptosis, oncosis, and necrosis: an overview of cell death,” American Journal of Pathology, vol. 146, no. 1, pp. 3–15, 1995. View at Google Scholar · View at Scopus
  5. K. N. Papanicolaou, G. A. Ngoh, E. R. Dabkowski et al., “Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death,” American Journal of Physiology, vol. 302, no. 1, pp. H167–H179, 2012. View at Publisher · View at Google Scholar
  6. D. C. Wallace, “Mitochondrial diseases in man and mouse,” Science, vol. 283, no. 5407, pp. 1482–1488, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Ramachandran, S. Jha, and D. J. Lefer, “Review paper: pathophysiology of myocardial reperfusion injury: the role of genetically engineered mouse models,” Veterinary Pathology, vol. 45, no. 5, pp. 698–706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Matas, N. Tien Sing Young, C. Bourcier-Lucas et al., “Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy,” Journal of Molecular and Cellular Cardiology, vol. 46, no. 3, pp. 420–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Begriche, A. Igoudjil, D. Pessayre, and B. Fromenty, “Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it,” Mitochondrion, vol. 6, no. 1, pp. 1–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ventura-Clapier, A. Garnier, V. Veksler, and F. Joubert, “Bioenergetics of the failing heart,” Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1360–1372, 2011. View at Publisher · View at Google Scholar
  11. S. Neubauer, “The failing heart-An engine out of fuel,” New England Journal of Medicine, vol. 356, no. 11, pp. 1140–1151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. I. R. Indran, G. Tufo, S. Pervaiz, and C. Brenner, “Recent advances in apoptosis, mitochondria and drug resistance in cancer cells,” Biochimica et Biophysica Acta, vol. 1807, no. 6, pp. 735–745, 2011. View at Publisher · View at Google Scholar
  13. F. Palmieri, “The mitochondrial transporter family (SLC25): physiological and pathological implications,” Pflugers Archiv European Journal of Physiology, vol. 447, no. 5, pp. 689–709, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Klingenberg, “The ADP and ATP transport in mitochondria and its carrier,” Biochimica et Biophysica Acta, vol. 1778, no. 10, pp. 1978–2021, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Gena, E. Fanelli, C. Brenner, M. Svelto, and G. Calamita, “News and views on mitochondrial water transport,” Frontiers in Bioscience, vol. 14, pp. 4189–4198, 2009. View at Google Scholar · View at Scopus
  16. D. R. Hunter, R. A. Haworth, and J. H. Southard, “Relationship between configuration, function, and permeability in calcium treated mitochondria,” Journal of Biological Chemistry, vol. 251, no. 16, pp. 5069–5077, 1976. View at Google Scholar · View at Scopus
  17. M. G. Vander Heiden, N. S. Chandel, E. K. Williamson, P. T. Schumacker, and C. B. Thompson, “Bcl-x(L) regulates the membrane potential and volume homeostasis of mitochondria,” Cell, vol. 91, no. 5, pp. 627–637, 1997. View at Google Scholar · View at Scopus
  18. E. Jacotot, L. Ravagnan, M. Loeffler et al., “The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore,” Journal of Experimental Medicine, vol. 191, no. 1, pp. 33–45, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. A. S. Belzacq-Casagrande, C. Martel, C. Pertuiset, A. Borgne-Sanchez, E. Jacotot, and C. Brenner, “Pharmacological screening and enzymatic assays for apoptosis,” Frontiers in Bioscience, vol. 14, pp. 3550–3562, 2009. View at Google Scholar · View at Scopus
  20. A. R. Halestrap, C. R. Connern, E. J. Griffiths, and P. M. Kerr, “Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury,” Molecular and Cellular Biochemistry, vol. 174, no. 1-2, pp. 167–172, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Piot, P. Croisille, P. Staat et al., “Effect of cyclosporine on reperfusion injury in acute myocardial infarction,” New England Journal of Medicine, vol. 359, no. 5, pp. 473–481, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. L. Nieminen, T. G. Petrie, J. J. Lemasters, and W. R. Selman, “Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons: evidence of the mitochondrial permeability transition,” Neuroscience, vol. 75, no. 4, pp. 993–997, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Blattner, L. He, and J. J. Lemasters, “Screening assays for the mitochondrial permeability transition using a fluorescence multiwell plate reader,” Analytical Biochemistry, vol. 295, no. 2, pp. 220–226, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Frezza, S. Cipolat, and L. Scorrano, “Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts,” Nature Protocols, vol. 2, no. 2, pp. 287–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Buron, M. Porceddu, M. Brabant et al., “Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization,” PloS One, vol. 5, no. 3, article e9924, 2010. View at Google Scholar
  26. M. Picard, T. Taivassalo, G. Gouspillou, and R. T. Hepple, “Mitochondria: isolation, structure and function,” Journal of Physiology, vol. 589, no. 18, pp. 4413–4421, 2011. View at Publisher · View at Google Scholar
  27. V. Petronilli, G. Miotto, M. Canton et al., “Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence,” Biophysical Journal, vol. 76, no. 2, pp. 725–734, 1999. View at Google Scholar · View at Scopus
  28. G. Zahrebelski, A. L. Nieminen, K. Al-Ghoul, T. Qian, B. Herman, and J. J. Lemasters, “Progression of subcellular changes during chemical hypoxia to cultured rat hepatocytes: a laser scanning confocal microscopic study,” Hepatology, vol. 21, no. 5, pp. 1361–1372, 1995. View at Google Scholar · View at Scopus
  29. A. L. Nieminen, A. K. Saylor, S. A. Tesfai, B. Herman, and J. J. Lemasters, “Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide,” Biochemical Journal, vol. 307, no. 1, pp. 99–106, 1995. View at Google Scholar · View at Scopus
  30. E. N. Dedkova and L. A. Blatter, “Measuring mitochondrial function in intact cardiac myocytes,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 1, pp. 48–61, 2012. View at Publisher · View at Google Scholar
  31. K. V. Rama Rao, A. R. Jayakumar, and M. D. Norenberg, “Ammonia neurotoxicity: role of the mitochondrial permeability transition,” Metabolic Brain Disease, vol. 18, no. 2, pp. 113–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Galluzzi, N. Zamzami, T. De La Motte Rouge, C. Lemaire, C. Brenner, and G. Kroemer, “Methods for the assessment of mitochondrial membrane permeabilization in apoptosis,” Apoptosis, vol. 12, no. 5, pp. 803–813, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. E. J. Griffiths and A. P. Halestrap, “Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion,” Biochemical Journal, vol. 307, no. 1, pp. 93–98, 1995. View at Google Scholar · View at Scopus
  34. A. P. Halestrap and C. Brenner, “The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death,” Current Medicinal Chemistry, vol. 10, no. 16, pp. 1507–1525, 2003. View at Google Scholar · View at Scopus
  35. C. P. Baines, R. A. Kaiser, N. H. Purcell et al., “Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death,” Nature, vol. 434, no. 7033, pp. 658–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Crompton, “Mitochondrial intermembrane junctional complexes and their role in cell death,” Journal of Physiology, vol. 529, no. 1, pp. 11–21, 2000. View at Google Scholar · View at Scopus
  37. D. Brdiczka, G. Beutner, A. Rück, M. Dolder, and T. Wallimann, “The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition,” BioFactors, vol. 8, no. 3-4, pp. 235–242, 1998. View at Google Scholar · View at Scopus
  38. A. P. Halestrap, “What is the mitochondrial permeability transition pore?” Journal of Molecular and Cellular Cardiology, vol. 46, no. 6, pp. 821–831, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Ricchelli, J. Šileikyte, and P. Bernardi, “Shedding light on the mitochondrial permeability transition,” Biochimica et Biophysica Acta, vol. 1807, no. 5, pp. 482–490, 2011. View at Publisher · View at Google Scholar
  40. I. Szabo and M. Zoratti, “The mitochondrial megachannel is the permeability transition pore,” Journal of Bioenergetics and Biomembranes, vol. 24, no. 1, pp. 111–117, 1992. View at Google Scholar · View at Scopus
  41. Y. H. Ko, M. Delannoy, J. Hullihen, W. Chiu, and P. L. Pedersen, “Mitochondrial ATP synthasome: cristae-enriched membranes and a multiwell detergent screening assay yield dispersed single complexes containing the ATP synthase and carriers for Pi and ADP/ATP,” Journal of Biological Chemistry, vol. 278, no. 14, pp. 12305–12309, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Jacotot, A. Deniaud, A. Borgne-Sanchez et al., “Therapeutic peptides: targeting the mitochondrion to modulate apoptosis,” Biochimica et Biophysica Acta, vol. 1757, no. 9-10, pp. 1312–1323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Loor and P. T. Schumacker, “Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion,” Cell Death and Differentiation, vol. 15, no. 4, pp. 686–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Tokarska-Schlattner, M. Zaugg, C. Zuppinger, T. Wallimann, and U. Schlattner, “New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics,” Journal of Molecular and Cellular Cardiology, vol. 41, no. 3, pp. 389–405, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. K. M. Broekemeier, M. E. Dempsey, and D. R. Pfeiffer, “Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria,” Journal of Biological Chemistry, vol. 264, no. 14, pp. 7826–7830, 1989. View at Google Scholar · View at Scopus
  46. E. J. Griffiths and A. P. Halestrap, “Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts,” Journal of Molecular and Cellular Cardiology, vol. 25, no. 12, pp. 1461–1469, 1993. View at Publisher · View at Google Scholar · View at Scopus
  47. S. J. Clarke, G. P. McStay, and A. P. Halestrap, “Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A,” Journal of Biological Chemistry, vol. 277, no. 38, pp. 34793–34799, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. D. J. Hausenloy, M. R. Duchen, and D. M. Yellon, “Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury,” Cardiovascular Research, vol. 60, no. 3, pp. 617–625, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. P. J. Henderson and H. A. Lardy, “Bongkrekic acid. An inhibitor of the adenine nucleotide translocase of mitochondria,” Journal of Biological Chemistry, vol. 245, no. 6, pp. 1319–1326, 1970. View at Google Scholar · View at Scopus
  50. M. Narita, S. Shimizu, T. Ito et al., “Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14681–14686, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Zamzami, C. E. Hamel, C. Maisse et al., “Bid acts on the permeability transition pore complex to induce apoptosis,” Oncogene, vol. 19, no. 54, pp. 6342–6350, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. S. A. Novgorodov, T. I. Gudz, Y. M. Milgrom, and G. P. Brierley, “The permeability transition in heart mitochondria is regulated synergistically by ADP and cyclosporin A,” Journal of Biological Chemistry, vol. 267, no. 23, pp. 16274–16282, 1992. View at Google Scholar · View at Scopus
  53. R. A. Haworth and D. R. Hunter, “Control of the mitochondrial permeability transition pore by high- affinity ADP binding at the ADP/ATP translocase in permeabilized mitochondria,” Journal of Bioenergetics and Biomembranes, vol. 32, no. 1, pp. 91–96, 2000. View at Publisher · View at Google Scholar
  54. A. C. Lee, M. Zizi, and M. Colombini, “β-NADH decreases the permeability of the mitochondrial outer membrane to ADP by a factor of 6,” Journal of Biological Chemistry, vol. 269, no. 49, pp. 30974–30980, 1994. View at Google Scholar · View at Scopus
  55. A. Deniaud, C. Rossi, A. Berquand et al., “Voltage-dependent anion channel transports calcium ions through biomimetic membranes,” Langmuir, vol. 23, no. 7, pp. 3898–3905, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Deniaud, O. Sharaf El Dein, E. Maillier et al., “Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis,” Oncogene, vol. 27, no. 3, pp. 285–299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. F. P. Thinnes, H. Florke, H. Winkelbach et al., “Channel active mammalian porin, purified from crude membrane fractions of human B lymphocytes or bovine skeletal muscle, reversibly binds the stilbene-disulfonate group of the chloride channel blocker DIDS,” Biological Chemistry Hoppe-Seyler, vol. 375, no. 5, pp. 315–322, 1994. View at Google Scholar · View at Scopus
  58. V. Shoshan-Barmatz, N. Keinan, S. Abu-Hamad, D. Tyomkin, and L. Aram, “Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo,” Biochimica et Biophysica Acta, vol. 1797, no. 6-7, pp. 1281–1291, 2010. View at Publisher · View at Google Scholar
  59. M. P. Rigobello, F. Turcato, and A. Bindoli, “Inhibition of rat liver mitochondrial permeability transition by respiratory substrates,” Archives of Biochemistry and Biophysics, vol. 319, no. 1, pp. 225–230, 1995. View at Publisher · View at Google Scholar
  60. D. Gincel, S. Silberberg, and V. Shoshan-Barmatz, “Modulation of the voltagedependent anion channel (VDAC) by glutamate,” Journal of Bioenergetics and Biomembranes, vol. 32, pp. 571–583, 2000. View at Google Scholar
  61. D. Gincel and V. Shoshan-Barmatz, “Glutamate interacts with VDAC and modulates opening of the mitochondrial permeability transition pore,” Journal of Bioenergetics and Biomembranes, vol. 36, no. 2, pp. 179–186, 2004. View at Publisher · View at Google Scholar
  62. A. M. Cesura, E. Pinard, R. Schubenel et al., “The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore,” Journal of Biological Chemistry, vol. 278, no. 50, pp. 49812–49818, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Krauskopf, O. Eriksson, W. J. Craigen, M. A. Forte, and P. Bernardi, “Properties of the permeability transition in VDAC1-/- mitochondria,” Biochimica et Biophysica Acta, vol. 1757, no. 5-6, pp. 590–595, 2006. View at Publisher · View at Google Scholar
  64. A. W. C. Leung, P. Varanyuwatana, and A. P. Halestrap, “The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition,” Journal of Biological Chemistry, vol. 283, no. 39, pp. 26312–26323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Fontaine, F. Ichas, and P. Bernardi, “A ubiquinone-binding site regulates the mitochondrial permeability transition pore,” Journal of Biological Chemistry, vol. 273, no. 40, pp. 25734–25740, 1998. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Elimadi, R. Sapena, A. Settaf, H. Le Louet, J. P. Tillement, and D. Morin, “Attenuation of liver normothermic ischemia—reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative,” Biochemical Pharmacology, vol. 62, no. 4, pp. 509–516, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Elimadi, V. Jullien, J. P. Tillement, and D. Morin, “S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant properties,” European Journal of Pharmacology, vol. 468, no. 2, pp. 93–101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Ascah, M. Khairallah, F. Daussin et al., “Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil,” American Journal of Physiology, vol. 300, no. 1, pp. H144–H153, 2011. View at Publisher · View at Google Scholar
  69. D. P. Millay, M. A. Sargent, H. Osinska et al., “Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy,” Nature Medicine, vol. 14, no. 4, pp. 442–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Bordet, B. Buisson, M. Michaud et al., “Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis,” Journal of Pharmacology and Experimental Therapeutics, vol. 322, no. 2, pp. 709–720, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. C. S. F. Queiroga, A. S. Almeida, C. Martel, C. Brenner, P. M. Alves, and H. L. A. Vieira, “Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mitochondrial membrane permeabilization and apoptosis,” Journal of Biological Chemistry, vol. 285, no. 22, pp. 17077–17088, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Azzolin, N. Antolini, A. Calderan et al., “Antamanide, a derivative of amanita phalloides, is a novel inhibitor of the mitochondrial permeability transition pore,” PLoS One, vol. 6, no. 1, article e16280, 2011. View at Publisher · View at Google Scholar
  73. N. Mewton, P. Croisille, G. Gahide et al., “Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction,” Journal of the American College of Cardiology, vol. 55, no. 12, pp. 1200–1205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Okorie, D. Bhavsar, D. Ridout et al., “Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore,” European Heart Journal, pp. 1266–1274, 2011. View at Google Scholar
  75. J. S. Kim, L. He, T. Qian, and J. J. Lemasters, “Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes,” Current Molecular Medicine, vol. 3, no. 6, pp. 527–535, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Qian, A. L. Nieminen, B. Herman, and J. J. Lemasters, “Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes,” American Journal of Physiology, vol. 273, no. 6, pp. C1783–C1792, 1997. View at Google Scholar · View at Scopus
  77. H. Friberg, M. Ferrand-Drake, F. Bengtsson, A. P. Halestrap, and T. Wieloch, “Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death,” Journal of Neuroscience, vol. 18, no. 14, pp. 5151–5159, 1998. View at Google Scholar · View at Scopus
  78. L. Khaspekov, H. Friberg, A. Halestrap, I. Viktorov, and T. Wieloch, “Cyclosporin A and its nonimmunosuppressive analogue N-Me-Val-4-cyclosporin A mitigate glucose/oxygen deprivation-induced damage to rat cultured hippocampal neurons,” European Journal of Neuroscience, vol. 11, no. 9, pp. 3194–3198, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Matsumoto, H. Friberg, M. Ferrand-Drake, and T. Wieloch, “Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion,” Journal of Cerebral Blood Flow and Metabolism, vol. 19, no. 7, pp. 736–741, 1999. View at Google Scholar · View at Scopus
  80. S. Malouitre, H. Dube, D. Selwood, and M. Crompton, “Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation,” Biochemical Journal, vol. 425, no. 1, pp. 137–148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. H. Dube, D. Selwood, S. Malouitre, M. Capano, M. I. Simone, and M. Crompton, “A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes,” Biochemical Journal, vol. 441, no. 3, pp. 901–907, 2012. View at Publisher · View at Google Scholar
  82. C. M. Porteous, A. Logan, C. Evans et al., “Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes,” Biochimica et Biophysica Acta, vol. 1800, no. 9, pp. 1009–1017, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. T. Miura, M. Tanno, and T. Sato, “Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis,” Cardiovascular Research, vol. 88, no. 1, pp. 7–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Feng, E. Lucchinetti, P. Ahuja, T. Pasch, J. C. Perriard, and M. Zaugg, “Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3β,” Anesthesiology, vol. 103, no. 5, pp. 987–995, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Javadov, V. Rajapurohitam, A. Kilić, A. Zeidan, A. Choi, and M. Karmazyn, “Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3β-dependent attenuation of mitochondrial dysfunction,” Journal of Molecular and Cellular Cardiology, vol. 46, no. 6, pp. 998–1007, 2009. View at Publisher · View at Google Scholar
  86. L. Gomez, M. Paillard, H. Thibault, G. Derumeaux, and M. Ovize, “Inhibition of GSK3β by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion,” Circulation, vol. 117, no. 21, pp. 2761–2768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. J. G. Pastorino, J. B. Hoek, and N. Shulga, “Activation of glycogen synthase kinase 3β disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity,” Cancer Research, vol. 65, no. 22, pp. 10545–10554, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Rasola, M. Sciacovelli, F. Chiara, B. Pantic, W. S. Brusilow, and P. Bernardi, “Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 2, pp. 726–731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. P. Pediaditakis, J. S. Kim, L. He, X. Zhang, L. M. Graves, and J. J. Lemasters, “Inhibition of the mitochondrial permeability transition by protein kinase A in rat liver mitochondria and hepatocytes,” Biochemical Journal, vol. 431, no. 3, pp. 411–421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. C. P. Baines, C. X. Song, Y. T. Zheng et al., “Protein kinase Cε interacts with and inhibits the permeability transition pore in cardiac mitochondria,” Circulation Research, vol. 92, no. 8, pp. 873–880, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. K. Takuma, P. Phuagphong, E. Lee, K. Mori, A. Baba, and T. Matsuda, “Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore,” Journal of Biological Chemistry, vol. 276, no. 51, pp. 48093–48099, 2001. View at Google Scholar · View at Scopus
  92. V. Borutaite, R. Morkuniene, O. Arandarcikaite, A. Jekabsone, J. Barauskaite, and G. C. Brown, “Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release,” Journal of Biomedical Science, vol. 16, no. 1, article 70, 2009. View at Publisher · View at Google Scholar
  93. M. Wyss, J. Smeitink, R. A. Wevers, and T. Wallimann, “Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism,” Biochimica et Biophysica Acta, vol. 1102, no. 2, pp. 119–166, 1992. View at Publisher · View at Google Scholar
  94. E. O'Gorman, G. Beutner, M. Dolder, A. P. Koretsky, D. Brdiczka, and T. Wallimann, “The role of creatine kinase in inhibition of mitochondrial permeability transition,” FEBS Letters, vol. 414, no. 2, pp. 253–257, 1997. View at Publisher · View at Google Scholar · View at Scopus
  95. G. Beutner, A. Rück, B. Riede, and D. Brdiczka, “Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases,” Biochimica et Biophysica Acta, vol. 1368, no. 1, pp. 7–18, 1998. View at Publisher · View at Google Scholar
  96. T. Miura, M. Nishihara, and T. Miki, “Drug development targeting the glycogen synthase kinase-3β (GSK-3β)-mediated signal transduction pathway: role of GSK-3β in myocardial protection against ischemia/reperfusion injury,” Journal of Pharmacological Sciences, vol. 109, no. 2, pp. 162–167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. G. Fajardo, M. Zhao, G. Berry, L.-J. Wong, D. Mochly-Rosen, and D. Bernstein, “β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways,” Journal of Molecular and Cellular Cardiology, vol. 51, no. 5, pp. 781–789, 2011. View at Publisher · View at Google Scholar
  98. J. M. Adams and S. Cory, “Life-or-death decisions by the Bcl-2 protein family,” Trends in Biochemical Sciences, vol. 26, no. 1, pp. 61–66, 2001. View at Publisher · View at Google Scholar · View at Scopus
  99. T. N. Chonghaile, K. A. Sarosiek, T.-T. Vo et al., “Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy,” Science, vol. 334, no. 6059, pp. 1129–1133, 2011. View at Publisher · View at Google Scholar
  100. F. Llambi, T. Moldoveanu, S. Tait et al., “A unified model of mammalian BCL-2 protein family interactions at the mitochondria,” Molecular Cell, vol. 44, no. 4, pp. 517–531, 2011. View at Publisher · View at Google Scholar
  101. I. Marzo, C. Brenner, N. Zamzami et al., “The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2-related proteins,” Journal of Experimental Medicine, vol. 187, no. 8, pp. 1261–1271, 1998. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Shimizu, M. Narita, and Y. Tsujimoto, “Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC,” Nature, vol. 399, no. 6735, pp. 483–487, 1999. View at Publisher · View at Google Scholar · View at Scopus
  103. Z. X. Chen and S. Pervaiz, “Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells,” Cell Death and Differentiation, vol. 14, no. 9, pp. 1617–1627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. K. N. Alavian, H. Li, L. Collis et al., “Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F 1 F O ATP synthase,” Nature Cell Biology, vol. 13, no. 10, pp. 1224–1233, 2011. View at Publisher · View at Google Scholar
  105. I. Marzo, C. Brenner, N. Zamzami et al., “Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis,” Science, vol. 281, no. 5385, pp. 2027–2031, 1998. View at Publisher · View at Google Scholar · View at Scopus
  106. C. Brenner, H. Cadiou, H. L. A. Vieira et al., “Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator,” Oncogene, vol. 19, no. 3, pp. 329–336, 2000. View at Google Scholar · View at Scopus
  107. A. S. Belzacq, H. L. A. Vieira, F. Verrier et al., “Bcl-2 and Bax modulate adenine nucleotide translocase activity,” Cancer Research, vol. 63, no. 2, pp. 541–546, 2003. View at Google Scholar · View at Scopus
  108. S. Shimizu, A. Konishi, T. Kodama, and Y. Tsujimoto, “BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3100–3105, 2000. View at Google Scholar · View at Scopus
  109. H. L. A. Vieira, P. Boya, I. Cohen et al., “Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-XL,” Oncogene, vol. 21, no. 13, pp. 1963–1977, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. R. Sugioka, S. Shimizu, T. Funatsu et al., “BH4-domain peptide from Bcl-xL exerts anti-apoptotic activity in vivo,” Oncogene, vol. 22, no. 52, pp. 8432–8440, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. M. Ono, Y. Sawa, M. Ryugo et al., “BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts,” European Journal of Cardio-thoracic Surgery, vol. 27, no. 1, pp. 117–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. D. Morin, R. Assaly, S. Paradis, and A. Berdeaux, “Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection,” Current Medicinal Chemistry, vol. 16, no. 33, pp. 4382–4398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. C. Plin, J. P. Tillement, A. Berdeaux, and D. Morin, “Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liver,” European Journal of Pharmacology, vol. 528, no. 1–3, pp. 162–168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  114. H. Ligeret, S. Barthelemy, R. Zini, J. P. Tillement, S. Labidalle, and D. Morin, “Effects of curcumin and curcumin derivatives on mitochondrial permeability transition pore,” Free Radical Biology and Medicine, vol. 36, no. 7, pp. 919–929, 2004. View at Publisher · View at Google Scholar · View at Scopus
  115. Z. Ungvari, W. E. Sonntag, R. De Cabo, J. A. Baur, and A. Csiszar, “Mitochondrial protection by resveratrol,” Exercise and Sport Sciences Reviews, vol. 39, no. 3, pp. 128–132, 2011. View at Publisher · View at Google Scholar
  116. S. Rimbaud, M. Ruiz, J. Piquereau et al., “Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure,” PLoS One, vol. 6, no. 10, article e26391, 2011. View at Publisher · View at Google Scholar
  117. M. Izem-Meziane, B. Djerdjouri, S. Rimbaud et al., “Catecholamine-induced cardiac mitochondrial dysfunction and mPTP opening: protective effect of curcumin,” American Journal of Physiology, vol. 302, no. 3, pp. H665–H674, 2012. View at Publisher · View at Google Scholar
  118. V. Tanwar, J. Sachdeva, M. Golechha, S. Kumari, and D. S. Arya, “Curcumin protects rat myocardium against isoproterenol-induced ischemic injury: attenuation of ventricular dysfunction through increased expression of hsp27 alongwith strengthening antioxidant defense system,” Journal of Cardiovascular Pharmacology, vol. 55, no. 4, pp. 377–384, 2010. View at Publisher · View at Google Scholar
  119. P. Manikandan, M. Sumitra, S. Aishwarya, B. M. Manohar, B. Lokanadam, and R. Puvanakrishnan, “Curcumin modulates free radical quenching in myocardial ischaemia in rats,” The International Journal of Biochemistry & Cell Biology, vol. 36, no. 10, pp. 1967–1980, 2004. View at Google Scholar · View at Scopus
  120. G. F. Kelso, C. M. Porteous, C. V. Coulter et al., “Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties,” Journal of Biological Chemistry, vol. 276, no. 7, pp. 4588–4596, 2001. View at Publisher · View at Google Scholar · View at Scopus
  121. D. Graham, N. N. Huynh, C. A. Hamilton et al., “Mitochondria-targeted antioxidant mitoq10 improves endothelial function and attenuates cardiac hypertrophy,” Hypertension, vol. 54, no. 2, pp. 322–328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Vergeade, P. Mulder, C. Vendeville-Dehaudt et al., “Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: prevention by the targeted antioxidant MitoQ,” Free Radical Biology and Medicine, vol. 49, no. 5, pp. 748–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. L. Plecitá-Hlavatá, J. Ježek, and P. Ježek, “Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 8-9, pp. 1697–1707, 2009. View at Publisher · View at Google Scholar
  124. J. M. Núñez-Córdoba and M. A. Martínez-González, “Antioxidant vitamins and cardiovascular disease,” Current Topics in Medicinal Chemistry, vol. 11, no. 14, pp. 1861–1869, 2011. View at Publisher · View at Google Scholar
  125. J. Q. Chen, P. R. Cammarata, C. P. Baines, and J. D. Yager, “Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications,” Biochimica et Biophysica Acta, vol. 1793, no. 10, pp. 1540–1570, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. V. Regitz-Zagrosek, S. Oertelt-Prigione, U. Seeland, and R. Hetzer, “Sex and gender differences in myocardial hypertrophy and heart failure,” Wiener Medizinische Wochenschrift, vol. 161, pp. 109–116, 2011. View at Google Scholar
  127. A. H. E. M. Maas, Y. T. Van Der Schouw, V. Regitz-Zagrosek et al., “Red alert for womens heart: the urgent need for more research and knowledge on cardiovascular disease in women,” European Heart Journal, vol. 32, no. 11, pp. 1362–1368, 2011. View at Publisher · View at Google Scholar
  128. S. P. Duckles and D. N. Krause, “Mechanisms of cerebrovascular protection: oestrogen, inflammation and mitochondria,” Acta Physiologica, vol. 203, no. 1, pp. 149–154, 2011. View at Publisher · View at Google Scholar
  129. C. M. Klinge, “Estrogenic control of mitochondrial function and biogenesis,” Journal of Cellular Biochemistry, vol. 105, no. 6, pp. 1342–1351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. K. A. Mattingly, M. M. Ivanova, K. A. Riggs, N. S. Wickramasinghe, M. J. Barch, and C. M. Klinge, “Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis,” Molecular Endocrinology, vol. 22, no. 3, pp. 609–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. R. Morkuniene, O. Arandarcikaite, L. Ivanoviene, and V. Borutaite, “Estradiol-induced protection against ischemia-induced heart mitochondrial damage and caspase activation is mediated by protein kinase G,” Biochimica et Biophysica Acta, vol. 1797, no. 6-7, pp. 1012–1017, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. C. Borrás, J. Gambini, R. López-Grueso, F. V. Pallardó, and J. Viña, “Direct antioxidant and protective effect of estradiol on isolated mitochondria,” Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 205–211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. R. Morkuniene, A. Jekabsone, and V. Borutaite, “Estrogens prevent calcium-induced release of cytochrome c from heart mitochondria,” FEBS Letters, vol. 521, no. 1-3, pp. 53–56, 2002. View at Publisher · View at Google Scholar · View at Scopus
  134. J. R. Muñoz-Castañeda, P. Montilla, M. C. Muñoz, I. Bujalance, J. Muntané, and I. Túnez, “Effect of 17-β-estradiol administration during adriamycin-induced cardiomyopathy in ovariectomized rat,” European Journal of Pharmacology, vol. 523, no. 1–3, pp. 86–92, 2005. View at Publisher · View at Google Scholar · View at Scopus
  135. R. Ventura-Clapier, B. Mettauer, and X. Bigard, “Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure,” Cardiovascular Research, vol. 73, no. 1, pp. 10–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. A. Garnier, D. Fortin, J. Zoll et al., “Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle,” FASEB Journal, vol. 19, no. 1, pp. 43–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  137. A. Ascensão, R. Ferreira, and J. Magalhães, “Exercise-induced cardioprotection—biochemical, morphological and functional evidence in whole tissue and isolated mitochondria,” International Journal of Cardiology, vol. 117, no. 1, pp. 16–30, 2007. View at Publisher · View at Google Scholar
  138. M. Ciminelli, A. Ascah, K. Bourduas, and Y. Burelle, “Short term training attenuates opening of the mitochondrial permeability transition pore without affecting myocardial function following ischemia-reperfusion,” Molecular and Cellular Biochemistry, vol. 291, no. 1-2, pp. 39–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  139. M. Marcil, K. Bourduas, A. Ascah, and Y. Burelle, “Exercise training induces respiratory substrate-specific decrease in Ca2+-induced permeability transition pore opening in heart mitochondria,” American Journal of Physiology, vol. 290, no. 4, pp. H1549–H1557, 2006. View at Publisher · View at Google Scholar
  140. A. Ascensão, J. Lumini-Oliveira, N. G. Machado et al., “Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats,” Clinical Science, vol. 120, no. 1, pp. 37–49, 2011. View at Publisher · View at Google Scholar